Topical Collection on antimicrobial Photodynamic Therapy

"Tackling the global threats caused by pathogens: New horizons for antimicrobial Photodynamic Therapy"

The Covid-19 pandemic caused by the SARS-CoV-2 coronavirus has created a great disruption of the personal, social, and professional life of the vast majority of the world’s population, owing to the limited scientific knowledge we still have on viral diseases and antiviral therapies. 

An unprecedented fast response by the global scientific community has led to the development of vaccines, which will hopefully allow us to overcome this sanitary crisis. However, one of the lessons learned is that we must increase our level of preparedness in anticipation of future pandemics. In this respect, it must be borne in mind that prior to the Covid-19 outbreak the scientific community warned of the imminent threat of pandemics caused by antibiotic-resistant bacteria. Pathogenic microorganisms, including viruses, bacteria, fungi, and protozoa, are susceptible to photodynamic inactivation, which has led to the emergence of antimicrobial photodynamic therapies. 

The topical collection “Tackling the global threats caused by pathogens: New horizons for antimicrobial Photodynamic Therapy” aims at providing a comprehensive overview of the status and perspectives of the field, in the hope that it will attract the interest of stakeholders ranging from basic scientists to governments, and including clinicians and industry. The topical issue is dedicated to Professor Michael R. Hamblin on the occasion of his retirement. Mike pioneered this field, tirelessly promoted it throughout his career, and was able to establish fruitful collaborations with fellow scientists around the world, thereby providing an example for us to follow. It is said that we are standing on the shoulders of giants, and Mike is certainly one of them.

To contribute, please submit your manuscript via our Submission System

Guest-edited by: Kristjan Plaetzer, Santi Nonell, Cristiano Viappiani and Tim Maisch